Parallax Volatility Advisers, L.P. Biogen Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $2.59 Million - $2.99 Million	-9,400 Reduced 77.05%	2,800 $797,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $23.6 Million - $26.9 Million	-91,900 Reduced 88.28%	12,200 $3.39 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $3.31 Million - $4.02 Million	-13,100 Reduced 11.18%	104,100 $28.8 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $21.4 Million - $29.5 Million	109,900 Added 1505.48%	117,200 $31.3 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $1.28 Million - $1.52 Million	6,800 Added 1360.0%	7,300 $1.49 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $15.9 Million - $20.1 Million	-82,300 Reduced 99.4%	500 $105,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.35 Million - $3.02 Million	-10,500 Reduced 11.25%	82,800 $19.9 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $8.69 Million - $11.3 Million	30,700 Added 49.04%	93,300 $26.4 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $3.29 Million - $5.27 Million	12,700 Added 25.45%	62,600 $21.7 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.61 Million - $5.44 Million	15,300 Added 44.22%	49,900 $12.2 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $5.67 Million - $6.54 Million	21,400 Added 162.12%	34,600 $9.81 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $3.08 Million - $4.08 Million	11,900 Added 915.38%	13,200 $3.53 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $13 Million - $16.5 Million	-48,400 Reduced 97.38%	1,300 $411,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $2.13 Million - $2.95 Million	9,700 Added 24.25%	49,700 $14.7 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $17.7 Million - $19.9 Million	-81,600 Reduced 67.11%	40,000 $9.31 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $12.1 Million - $13.3 Million	-55,000 Reduced 31.14%	121,600 $28.4 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $15.5 Million - $24.2 Million	-71,300 Reduced 28.76%	176,600 $41.7 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $60.4 Million - $76.4 Million	216,700 Added 694.55%	247,900 $74.6 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $9.16 Million - $12 Million	31,200 New	31,200 $11 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account